Skip to content

Clinical Study Protocol of Multicenter Randomized Controlled Study of Artificial Intelligence-based Qihuang Needle Therapy to Improve Gait Impairment in Parkinson's Disease

Clinical Study Protocol of Multicenter Randomized Controlled Study of Artificial Intelligence-based Qihuang Needle Therapy to Improve Gait Impairment in Parkinson's Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000121
Enrollment
Unknown
Registered
2026-01-22
Start date
2026-02-15
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Acupuncture group:Qi Huang Needle Treatment
Comfort needle group:Comfort needle treatment

Sponsors

The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1)Meets the diagnostic criteria for Parkinson's disease; 2)Has a history of Parkinson's disease for 5 years or more; 3)Is in Hoehn-Yahr stages 1-4; 4)Can walk for more than 6 minutes without using equipment; 5)Ages between 25 and 80; 6)Has a Mini-Mental State Examination (MMSE) score of =24.

Exclusion criteria

Exclusion criteria: 1) Parkinson's syndrome due to various causes such as cerebrovascular disease and poisoning, progressive supranuclear palsy, multiple system atrophy, Lewy body dementia, and corticobasal degeneration; 2) Those with significant major diseases, including severe liver or kidney failure, blood disorders, tumors, endocrine diseases, or chronic pain; 3) A history of other neurological disorders (such as stroke, epilepsy, multiple sclerosis) or psychiatric conditions (like severe depression, schizophrenia, bipolar disorder); 4) Currently pregnant; 5) History of heart pacemaker implantation or surgery involving implanted devices (arteriovenous malformation clips or brain or spinal cord electrodes).

Design outcomes

Primary

MeasureTime frame
Gait speed and stride length;

Secondary

MeasureTime frame
Unified Parkinson's Disease Rating Scale Part III;Freezing of Gait Questionnaire;Timed Up and Go Test,TUGT;The frequency and dosage of basic treatment drugs for Parkinson's disease;

Countries

China

Contacts

Public ContactZhenhu Chen

The First Affiliated Hospital of Guangzhou University of Chinese Medicine

zhchen@gzucm.edu.cn13728063180

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 7, 2026